<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01151618</url>
  </required_header>
  <id_info>
    <org_study_id>HRC-1018-FOTVal-SS</org_study_id>
    <nct_id>NCT01151618</nct_id>
  </id_info>
  <brief_title>Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation</brief_title>
  <official_title>Evaluating Forced Oscillation Technique (FOT) in Abolishing Flow Limitation in Patients With Stable Chronic Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To validate the capability of the Respironics Synchrony ventilator to properly detect
      Expiratory Flow Limitation (EFL) as compared to the gold standard method of detecting EFL via
      the Mead and Wittenberger technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Positive end expiratory pressure (PEEP) is used in COPD patients to counteract the intrinsic
      PEEP (PEEPi), which represents the end expiratory recoil pressure of the total respiratory
      system due to the presence of dynamic hyperinflation (DH).

      DH commonly occurs in COPD, where the presence of expiratory flow-limitation (EFL) requires
      the patient to breath at higher lung volumes to produce the necessary after appropriate leak
      correction, showed a sensitivity and specificity in detecting EFL expiratory flow. To be
      effective, the PEEP level applied to the patient should be equal to PEEPi.

      The continuous monitoring of EFL could be a useful tool to select the minimum PEEP level
      required to abolish it.

      EFL can be detected using the forced oscillation technique (FOT) by an index which
      quantifies, for each breath, the within-breath variations of respiratory reactance (delta
      Xrs) at 5Hz.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of Expiratory Flow Limitation</measure>
    <time_frame>within 2 hours</time_frame>
    <description>Expiratory flow limitation (EFL) is an increase in transpulmonary pressure (cmH2O) with no change expiratory flow (lpm).
Expiratory Flow Limitation or absence thereof will be detected by using a measurement of changes in reactance (DeltaXrs - cmH2O*s/L) it will be compared to the the Mead and Whittenberger technique (via esophageal balloon measuring transpulmonary pressures).
Two measurements will be obtained, DeltaXrs and Transpulmonary pressure. Comparisons of these measurements will be made to determine if the participant exhibits EFL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Detection of Expiratory Flow Limitation by a Commercial Mechanical Ventilator</measure>
    <time_frame>2 hours</time_frame>
    <description>Number of participants found to have expiratory flow limitation as determined by a commercial mechanical ventilator.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Detection of Expiratory Flow Limitation by Mead and Wittenberger (M-W) Technique</measure>
    <time_frame>2 hours</time_frame>
    <description>Number of breaths are cumulative across all participants were found to be flow limited, not-flow limited or indeterminate as determined by the Mead and Wittenberger (M-W) technique of esophageal pressure. Each participant's individual breaths was imported into Matlab software program that displayed the flow vs transpleural pressure and breaths were individually analyzed according to the Mead Wittenberger technique.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Respironics Synchrony ventilator (Non Invasive Ventilation)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respironics Synchrony ventilator (Non Invasive Ventilation)</intervention_name>
    <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
    <arm_group_label>Respironics Synchrony ventilator (Non Invasive Ventilation)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Age &lt; 80 years

          2. Moderate - Severe COPD diagnosed by spirometry (according to the GOLD criteria -
             Global Initiative for Chronic Obstructive Lung Disease criteria)

          3. Free from any exacerbation in the 6 weeks preceding the study

        Exclusion Criteria

          1. Any co-existing cardio-pulmonary conditions which may result in a picture of
             ventilatory failure such as congestive cardiac failure, chest wall or neuromuscular
             disease, bronchopneumonia, pulmonary fibrosis, bronchiectasis, cystic fibrosis or
             obesity-hypoventilation syndrome

          2. Clinically unstable; exacerbation within the preceding 6 weeks

          3. The presence of pulmonary or extra-pulmonary neoplasia that is still active

          4. The presence of a bleeding diathesis

          5. Unstable coronary artery disease

          6. Presence of tuberculosis, current infection or potentially infectious pathogen

          7. Inability to provide informed consent to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Calverley, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aintree University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aintree</name>
      <address>
        <city>Liverpool</city>
        <zip>L97AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 21, 2010</study_first_submitted>
  <study_first_submitted_qc>June 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2010</study_first_posted>
  <results_first_submitted>February 24, 2011</results_first_submitted>
  <results_first_submitted_qc>March 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 18, 2019</results_first_posted>
  <last_update_submitted>March 15, 2019</last_update_submitted>
  <last_update_submitted_qc>March 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited and screened with spirometry and determination of expiratory flow limitation prior to being enrolled into the study.</recruitment_details>
      <pre_assignment_details>22 patient were recruited in June of 2010.
13 patients studied
(7 didnâ€™t tolerate balloon; 2 had an exacerbation )</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Therapy Arm</title>
          <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Therapy Arm</title>
          <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Detection of Expiratory Flow Limitation</title>
        <description>Expiratory flow limitation (EFL) is an increase in transpulmonary pressure (cmH2O) with no change expiratory flow (lpm).
Expiratory Flow Limitation or absence thereof will be detected by using a measurement of changes in reactance (DeltaXrs - cmH2O*s/L) it will be compared to the the Mead and Whittenberger technique (via esophageal balloon measuring transpulmonary pressures).
Two measurements will be obtained, DeltaXrs and Transpulmonary pressure. Comparisons of these measurements will be made to determine if the participant exhibits EFL.</description>
        <time_frame>within 2 hours</time_frame>
        <population>All participants that completed the protocol were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Therapy Arm</title>
            <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Expiratory Flow Limitation</title>
          <description>Expiratory flow limitation (EFL) is an increase in transpulmonary pressure (cmH2O) with no change expiratory flow (lpm).
Expiratory Flow Limitation or absence thereof will be detected by using a measurement of changes in reactance (DeltaXrs - cmH2O*s/L) it will be compared to the the Mead and Whittenberger technique (via esophageal balloon measuring transpulmonary pressures).
Two measurements will be obtained, DeltaXrs and Transpulmonary pressure. Comparisons of these measurements will be made to determine if the participant exhibits EFL.</description>
          <population>All participants that completed the protocol were analyzed.</population>
          <units>cmH2O*s/L</units>
          <param>Least Squares Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" lower_limit="2" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Sensitivity and Specificity of values with respect to the Mead Whittenberger method were computed as follows (FL=flow limited and NFL = Non Flow limited):
Sensitivity = (# of FL breaths detected by FOT / # of FL breaths detected by M&amp;W) * 100 Specificity =(# of NFL breaths detected by FOT / # of NFL breaths detected by M&amp;W) * 100</non_inferiority_desc>
            <param_type>DeltaXrs (cmH2O*s/L)</param_type>
            <param_value>2.6</param_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
            <estimate_desc>DeltaXrs equals average inspiratory reactance minus average expiratory reactance.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Detection of Expiratory Flow Limitation by a Commercial Mechanical Ventilator</title>
        <description>Number of participants found to have expiratory flow limitation as determined by a commercial mechanical ventilator.</description>
        <time_frame>2 hours</time_frame>
        <population>All participants that completed the protocol were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Therapy Arm</title>
            <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Expiratory Flow Limitation by a Commercial Mechanical Ventilator</title>
          <description>Number of participants found to have expiratory flow limitation as determined by a commercial mechanical ventilator.</description>
          <population>All participants that completed the protocol were analyzed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Flow limited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Flow Limited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Detection of Expiratory Flow Limitation by Mead and Wittenberger (M-W) Technique</title>
        <description>Number of breaths are cumulative across all participants were found to be flow limited, not-flow limited or indeterminate as determined by the Mead and Wittenberger (M-W) technique of esophageal pressure. Each participant's individual breaths was imported into Matlab software program that displayed the flow vs transpleural pressure and breaths were individually analyzed according to the Mead Wittenberger technique.</description>
        <time_frame>2 hours</time_frame>
        <population>All participants that completed the protocol were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Therapy Arm</title>
            <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Expiratory Flow Limitation by Mead and Wittenberger (M-W) Technique</title>
          <description>Number of breaths are cumulative across all participants were found to be flow limited, not-flow limited or indeterminate as determined by the Mead and Wittenberger (M-W) technique of esophageal pressure. Each participant's individual breaths was imported into Matlab software program that displayed the flow vs transpleural pressure and breaths were individually analyzed according to the Mead Wittenberger technique.</description>
          <population>All participants that completed the protocol were analyzed.</population>
          <units>breaths</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Flow limited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="534"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Flow Limited</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indeterminate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1396"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Over course of the study which was 3 months in duration.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Therapy Arm</title>
          <description>Non Invasive Ventilation using forced oscillation technique (FOT)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease Exacerbation</sub_title>
                <description>2 participants had COPD exacerbations after consent but prior to study treatment.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bob Romano, Biomedical Engineer</name_or_title>
      <organization>Philips Respironics</organization>
      <phone>724-387-7781</phone>
      <email>bob.romano@philips.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

